Literature DB >> 23168237

Hepatic cytokine response can be modulated using the Kupffer cell blocker gadolinium chloride in obstructive jaundice.

C Jones1, S A Badger, M Hoper, R W Parks, T Diamond, M A Taylor.   

Abstract

INTRODUCTION: Depletion of Kupffer cells by gadolinium chloride (GdCl(3)) reduces the systemic response during sepsis. The study aim was to investigate the effect of this depletion on hepatic proinflammatory cytokine response to portal endotoxaemia.
METHODS: Sixteen Wistar rats were randomised to receive either saline IV (n = 8) or GdCl(3) (10 mg/kg IV, n = 8) six days after bile duct ligation (BDL). 24 h later the animals were perfused for 2 h, using isolated hepatic perfusion. Aliquots of effluent perfusate were collected at 20-min intervals for cytokine analysis. Sections of liver were sampled and the hepatic Kupffer cell number of each group was measured using ED1 immunohistochemistry.
RESULTS: Pre-treatment with GdCl(3) resulted in significantly reduced serum bilirubin concentrations but significantly elevated serum ALP and AST levels compared to the control group. It was also associated with a significant reduction in Kupffer cell numbers and a corresponding significant reduction in hepatic TNFα and IL-6 production in response to portal endotoxaemia.
CONCLUSIONS: Pre-treatment with GdCl(3) in jaundiced animals reduced Kupffer cell numbers, attenuated liver enzyme abnormalities and reduced TNFα and IL-6 in response to portal endotoxaemia. Hepatic Kupffer cells, therefore, play a significant role in the development of an exaggerated inflammatory response in obstructive jaundice.
Copyright © 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23168237     DOI: 10.1016/j.ijsu.2012.11.008

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  4 in total

Review 1.  Pathogenesis of Kupffer Cells in Cholestatic Liver Injury.

Authors:  Keisaku Sato; Chad Hall; Shannon Glaser; Heather Francis; Fanyin Meng; Gianfranco Alpini
Journal:  Am J Pathol       Date:  2016-07-22       Impact factor: 4.307

2.  TGR5 protects against cholestatic liver disease via suppressing the NF-κB pathway and activating the Nrf2/HO-1 pathway.

Authors:  Haojun Yang; Fengyong Luo; Yi Wei; Yuwen Jiao; Jun Qian; Shuai Chen; Yu Gong; Liming Tang
Journal:  Ann Transl Med       Date:  2021-07

3.  Gadolinium chloride suppresses acute rejection and induces tolerance following rat liver transplantation by inhibiting Kupffer-cell activation.

Authors:  Yakun Wu; Yunbing Wang; Min Li; Xiaoli Yang; Jianping Gong; Wei Zhang
Journal:  Exp Ther Med       Date:  2014-10-10       Impact factor: 2.447

4.  Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct-Ligated Mouse.

Authors:  Shi-Ying Cai; Maoxu Ge; Albert Mennone; Rafaz Hoque; Xinshou Ouyang; James L Boyer
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2019-12-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.